Amneal Pharmaceuticals (AMRX) News Today → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free AMRX Stock Alerts $6.47 -0.12 (-1.82%) (As of 05/9/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLSV Asset Management Has $6.61 Million Stock Position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)marketbeat.com - May 9 at 6:39 AMThe Goldman Sachs Group Increases Amneal Pharmaceuticals (NASDAQ:AMRX) Price Target to $8.00americanbankingnews.com - May 8 at 5:40 AMTruist Financial Reiterates "Buy" Rating for Amneal Pharmaceuticals (NASDAQ:AMRX)americanbankingnews.com - May 8 at 4:04 AMAssessing Amneal Pharmaceuticals: Insights From 4 Financial Analystsmarkets.businessinsider.com - May 6 at 4:02 PMAmneal Pharmaceuticals First Quarter 2024 Earnings: US$0.30 loss per share (vs US$0.046 loss in 1Q 2023)finance.yahoo.com - May 6 at 4:02 PMThe Goldman Sachs Group Boosts Amneal Pharmaceuticals (NASDAQ:AMRX) Price Target to $8.00marketbeat.com - May 6 at 12:14 PMAmneal Pharmaceuticals (NASDAQ:AMRX) Stock Rating Reaffirmed by Truist Financialmarketbeat.com - May 6 at 8:47 AMAmneal Pharmaceuticals: A Strong Buy on Robust Growth and Promising Pipelinemarkets.businessinsider.com - May 6 at 12:06 AMAmneal Pharmaceuticals (NASDAQ:AMRX) Sets New 52-Week High at $6.90americanbankingnews.com - May 5 at 5:18 AMAmneal Pharmaceuticals, Inc. (NYSE:AMRX) Q1 2024 Earnings Call Transcriptmsn.com - May 4 at 9:29 AMAmneal Pharmaceuticals Inc (AMRX) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...finance.yahoo.com - May 4 at 4:04 AMAmneal Pharmaceuticals (NASDAQ:AMRX) Hits New 12-Month High at $6.90marketbeat.com - May 3 at 10:51 PMAmneal Pharmaceuticals (NASDAQ:AMRX) Issues FY 2024 Earnings Guidancemarketbeat.com - May 3 at 8:35 PMGeneric Drugmaker Amneal Announces Over $270M In US Opioid Lawsuit Settlementmsn.com - May 3 at 4:11 PMAmneal stock climbs on Q1 report, opioid settlement updatemsn.com - May 3 at 4:11 PMAmneal Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentationseekingalpha.com - May 3 at 1:38 PMAMRX Stock Earnings: Amneal Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024msn.com - May 3 at 11:07 AMDrugmaker Amneal agrees to $270 million U.S. opioid settlementreuters.com - May 3 at 11:00 AMAmneal: Q1 Earnings Snapshotwashingtonpost.com - May 3 at 7:42 AMAmneal Reports First Quarter 2024 Financial Resultsbusinesswire.com - May 3 at 6:00 AMAmneal Pharmaceuticals Q1 2024 Earnings Previewmsn.com - May 2 at 1:08 PMAnalysts Offer Insights on Healthcare Companies: Bio-Techne (TECH) and Amneal Pharmaceuticals (AMRX)markets.businessinsider.com - May 2 at 8:07 AMAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Consensus Recommendation of "Buy" from Brokeragesamericanbankingnews.com - May 2 at 3:22 AMCalifornia is joining with a New Jersey company to make a generic opioid overdose reversal drugmsn.com - April 30 at 2:10 AMCalifornia teams with Amneal Pharma for cheaper, generic version of Narcanmsn.com - April 30 at 1:49 AMCalifornia is joining with a New Jersey company to buy a generic opioid overdose reversal drugmsn.com - April 29 at 10:32 AMAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Short Interest Updateamericanbankingnews.com - April 29 at 3:44 AMAmneal Pharmaceuticals (NASDAQ:AMRX) Trading Down 7.1%marketbeat.com - April 25 at 8:44 PMAllspring Global Investments Holdings LLC Sells 146,925 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)marketbeat.com - April 25 at 4:33 AMAmneal Pharmaceuticals Shares Rise 9% After FDA Approves Naloxone Spraymarketwatch.com - April 24 at 3:01 PMAmneal's OTC Naloxone Nasal Spray Receives FDA Approval For Opioid Overdose Emergency Treatmentmarkets.businessinsider.com - April 24 at 9:17 AMAmneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdosebusinesswire.com - April 24 at 8:00 AMAmneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicinebusinesswire.com - April 16 at 8:00 AMAmneal Pharmaceuticals (NASDAQ:AMRX) shareholders are still up 235% over 1 year despite pulling back 8.0% in the past weekfinance.yahoo.com - April 15 at 8:42 AMPhocas Financial Corp. Buys Shares of 714,890 Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)marketbeat.com - April 14 at 12:59 PMAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Short Interest Up 15.9% in Marchmarketbeat.com - April 14 at 7:50 AMAlkermes' Innovations Are Transforming Mental Health Treatmentsfinance.yahoo.com - April 11 at 3:01 PMAmneal Pharmaceuticals (NASDAQ:AMRX) Stock Price Up 1.9%marketbeat.com - April 10 at 2:51 PMAmneal to Report First Quarter 2024 Results on May 3, 2024businesswire.com - April 10 at 8:00 AM3 Lucrative Pharma Stocks to Diversify Your Investmentsstocknews.com - April 9 at 6:02 PMAmneal Pharmaceuticals (NASDAQ:AMRX) Stock Price Down 2.2%marketbeat.com - April 9 at 11:46 AMBausch Health drops after suing Amneal Pharma over Xifaxan genericmsn.com - April 8 at 4:09 PMVanguard Group Inc. Boosts Stock Position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)marketbeat.com - April 8 at 4:09 AMAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Stock Position Decreased by Assenagon Asset Management S.A.marketbeat.com - April 7 at 4:36 AMBausch Health Sues Amneal Over IBS Treatment Patentmarketwatch.com - April 5 at 8:38 PMAmneal Pharmaceuticals (NASDAQ:AMRX) Sees Strong Trading Volumemarketbeat.com - April 3 at 1:56 PMAmneal to Ring the Nasdaq Closing Bell on April 2, 2024businesswire.com - March 28 at 4:05 PMAmneal gains FDA greenlight to develop Ciprodex generic for ear infectionsmsn.com - March 27 at 2:52 AMAmneal Pharma Receives FDA Approval For Ciprofloxacin And Dexamethasone Otic Suspensionmarkets.businessinsider.com - March 25 at 10:31 PMAmneal Pharma Gets FDA Nod for Infection Fighting Drug Combinationmarketwatch.com - March 25 at 4:35 PM Get Amneal Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Proof that the Musk/Bezos rivalry is about to hit a new level (Ad)Elon Musk Humiliated Since Jeff Bezos and Elon Musk first met in 2004 — they've been involved in a bitter feud… from rockets, to electric vehicles to who's the world richest person…for going on two decades these two have been at each others throats… Go here now for full story. AMRX Media Mentions By Week AMRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMRX News Sentiment▼0.330.39▲Average Medical News Sentiment AMRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMRX Articles This Week▼253▲AMRX Articles Average Week Get Amneal Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: GPCR News Today SNDX News Today AGIO News Today EVO News Today CPRX News Today GLPG News Today NAMS News Today RNA News Today SUPN News Today RCKT News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMRX) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersProof that the Musk/Bezos rivalry is about to hit a new levelInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amneal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
